(Q80470630)

English

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

scientific article published on 13 June 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Helicobacter pylori

1 reference

based on heuristic

inferred from title

(RS)-rabeprazole

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Naohito Shirai

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mitsushige Sugimoto

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Chise Kodaira

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Masafumi Nishino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Mutsuhiro Ikuma

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Masayoshi Kajimura

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kyoichi Ohashi

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takashi Ishizaki

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Akira Hishida

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Takahisa Furuta

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

13 June 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

63

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

743-749

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17565490%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

https://scigraph.springernature.com/pub.10.1007/s00228-007-0302-8

0 references

Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of lansoprazole and famotidine for gastric acid inhibition during the daytime and night-time in different CYP2C19 genotype groups

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical studies of 13C-urea breath test in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Furazolidone-based triple 'rescue therapy' vs. quadruple 'rescue therapy' for the eradication of Helicobacter pylori resistant to metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of lung tumors and lymphomas in BALB/c mice by metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retreatment of H. pylori with dual therapy using high doses of rabeprazole or lansoprazole can be effective

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics of omeprazole (a substrate of CYP2C19) and comparison with two mutant alleles, C gamma P2C19m1 in exon 5 and C gamma P2C19m2 in exon 4, in Japanese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer after exposure to metronidazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of evidence for cancer due to use of metronidazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of a new selective medium for Campylobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitive detection of Helicobacter pylori by using polymerase chain reaction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metronidazole and cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of CYP2C19 polymorphism and Helicobacter pylori genotype determined from gastric tissue samples on response to triple therapy for H pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the kinetic disposition and metabolism of E3810, a new proton pump inhibitor, and omeprazole in relation to S-mephenytoin 4'-hydroxylation status

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori infection and the development of gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori infection and gastric lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interethnic differences in omeprazole metabolism in the two S-mephenytoin hydroxylation phenotypes studied in Caucasians and Orientals

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

1 reference

https://pubmed.ncbi.nlm.nih.gov/17565490

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q80470630&oldid=1756744446"